Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-07-02

FDA Approved: SILODOSIN — Supplemental Application (Aurobindo Pharma Limited)

View source ↗

Summary

The FDA approved a supplemental application for a generic silodosin product from Aurobindo Pharma Limited. This action approves the generic formulation under an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Silodosin (Silodosin)

Snippet

SUPPL AP for SILODOSIN (SILODOSIN)